References
-
1) Mesenchymal Stem Cells Improve Cognitive Impairment and Reduce Aβ Deposition via Promoting AQP4 Polarity and Relieving Neuroinflammation in Rats With Chronic Hypertension-Induced Cerebral Small-Vessel Disease.
-
2) Cobratoxin Alleviates Cancer-Induced Bone Pain in Rats via Inhibiting CaMKII Signaling Pathway after Acting on M4 Muscarinic Cholinergic Receptors.
-
3) Identification by RNA-Seq of let-7 clusters as prenatal biomarkers for nonsyndromic cleft lip with palate.
-
4) Myristic acid alleviates hippocampal aging correlated with GABAergic signaling.
-
5) Identification and characterization of two novel noncoding tyrosinase (TYR) gene variants leading to oculocutaneous albinism type 1.
-
6) Atractylodin alleviates nonalcoholic fatty liver disease by regulating Nrf2-mediated ferroptosis.
-
7) Protections of transcription factor BACH2 and natural product myricetin against pathological cardiac hypertrophy and dysfunction.
-
8) Lonicera caerulea Berry Polyphenols Extract Alleviates Exercise Fatigue in Mice by Reducing Oxidative Stress, Inflammation, Skeletal Muscle Cell Apoptosis, and by Increasing Cell Proliferation.
-
9) LOX-1 attenuates high glucose-induced autophagy via AMPK/HNF4α signaling in HLSECs.
-
10) Removing the sporoderm from the sporoderm-broken spores of Ganoderma lucidum improves the anticancer and immune-regulatory activity of the water-soluble polysaccharide.
-
11) Selenium Nanoparticles Improved Intestinal Health Through Modulation of the NLRP3 Signaling Pathway.
-
12) Augmentation of 3β-hydroxysteroid-Δ24 Reductase (DHCR24) Expression Induced by Bovine Viral Diarrhea Virus Infection Facilitates Viral Replication via Promoting Cholesterol Synthesis.
-
13) Activation of the Chemokine Receptor CCR1 and Preferential Recruitment of Gαi Suppress RSV Replication: Implications for Developing Novel Respiratory Syncytial Virus Treatment Strategies.
-
14) Obesity by High-Fat Diet Increases Pain Sensitivity by Reprogramming Branched-Chain Amino Acid Catabolism in Dorsal Root Ganglia.
-
15) Zafirlukast inhibits the growth of lung adenocarcinoma via inhibiting TMEM16A channel activity.